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Methods: Cross-sectional catchment area surveys were performed in Cuba, Mexico, Venezuela,
Peru, Dominican Republic, Puerto Rico, China, and India. In 16,538 older adults (65 years of
age), significant weight loss was self-reported and confirmed by an informant. We conducted neuro-
psychological testing and clinical and neurological assessments. Dementia severity was determined
by applying a validated algorithm and was quantified by the Clinical Dementia Rating Scale.
Results: The characteristics of those who reported weight loss varied across countries. In Poisson
models, after controlling for relevant covariates and for waist and arm circumferences, dementia se-
verity was associated with reported weight loss (pooled prevalence ratios [95% confidence intervals
{CI}] 2.19 [1.98, 2.41]; 3.81 [3.35, 4.33]; and 5.18 [4.41, 6.10] for CDR 0.5, 1, and 2/3, respectively,
compared with CDR 0). The association increased linearly through stages of dementia severity in all
countries (P for trend , .001), and between-country heterogeneity was minimal.
Conclusions: We found a strong gradient effect in the direct association between dementia severity
and reported weight loss, homogeneous across sites from eight countries, consistent with mechanistic
data on the role of neurodegenerative processes on energy balance and with dietary changes due to
disease severity. Considering the well-recognized effect of weight loss on morbidity and mortality
and the large number affected by dementia in less resourced countries, amelioration of weight loss
in dementia patients should be considered with priority in these settings.
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Weight loss in older adults is associatedwith increased dis-
ability and mortality risk [1]. Along with cancer and chronic
diseases, dementia is a well-recognized source of weight loss.
Weight loss accrues with dementia severity and may in
part be explained by reduced food intake because of im-
paired autonomy, eating disturbances, and reduced appetite
[2]. However, mechanisms underlying weight loss in demen-thor. Tel.: 301-496-6048; Fax: 301-496-4006.
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Open access under CC BY licetia remain unclear. Dementia neuropathology was inversely
related to body mass index (BMI) in a recent postmortem
study [3], and neurodegenenerative processes during the pre-
symptomatic stage of the disease [4] may be responsible for
involuntary weight loss [2] several years before the clinical
onset of dementia [5,6]. Epidemiologic evidence on the
association between dementia and weight loss is lacking
from low- and middle-income countries (LAMICs), where
most people with dementia currently live [7] and where
health-care systems and services are underresourced and
less suited to the long-term needs of those affected by dis-
abling chronic diseases [8].nse.
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logic investigation in which standardized procedures have
been applied in identical surveys of over 17,000 older adults
in LAMICs. The aim of the present analysis was to study the
cross-sectional association between dementia severity, as
quantified by the Clinical Dementia Rating Scale (CDR),
and weight loss in each of these countries. We explored
whether this association increased linearly through stages
of dementia severity, and we formally measured heterogene-
ity across countries. Given the cross-sectional association
between dementia severity and reduced lean mass [9], and
because we have previously reported that dementia was
cross-sectionally associated with low arm and waist circum-
ferences in the 10/66 cohorts [10], we also considered their
role in the association between dementia severity and weight
loss.2. Methods
2.1. Study design
The 10/66 surveys were performed using a one-phase de-
sign between January 2003 and July 2010 in urban and rural
sites in Mexico, Peru, India, and China and in urban sites
only in Cuba, Dominican Republic, Venezuela, and Puerto
Rico. All older adults aged 65 years who resided in spec-
ified catchment areas were eligible with no exclusion crite-
ria. Target sample sizes of 2000 per country were based on
power calculations at 80% for an expected dementia preva-
lence of 4.5% (60.9).
Details on the full 10/66 study protocol have been previ-
ously published [11]. In brief, measurements administered
comprised a range of clinical and neurological assessments
and structured questionnaires, including an informant inter-
view, which were administered at the participants’ homes by
health workers or junior doctors (in Cuba and China), all of
who received 1 week of training. Interviews and assessments
followed a strict standard procedure, and the study protocol
was translated into local languages. Local principal investi-
gators conducted the studies under continuous supervision
and with the assistance of the London coordinating center.
2.2. Weight loss
We defined weight loss of clinical significance in older
people as .10 lb (4.5 kg), consistent with the geriatric syn-
drome of sarcopenia [12], and with studies on weight loss
and mortality [13]. Weight loss was self-reported by partic-
ipants, who answered the following question: “Have you lost
more than 4.5 kg of body weight during the past 3 months?”
For participants who were unable to quantify their weight
loss with sufficient precision, interviewers explained that
10 lb/4.5 kg represents “significant weight loss.” The accept-
ability and appropriateness of this measure is supported by
qualitative data obtained from the interviewers who re-
corded that weight loss was reported along with, for exam-
ple, comments on “looser clothes” and “need to tighten thebelt.” Moreover, reported weight loss was confirmed by
a second source in the case of incapacity or cognitive impair-
ment (this was the case for 2562 participants), and in the case
of discrepancy, caregiver report was given salience.2.3. Dementia diagnosis and severity
We used the 10/66 algorithm on the basis of information
from the Community Screening Instrument for Dementia
(CSI-D; composed of a participant cognitive examination
and structured informant questionnaire regarding cognitive
decline) [14], a modified version of the Consortium to Estab-
lish a Registry for Alzheimer’s Disease (CERAD) 10-word
recall task, and the Geriatric Mental State fully-structured
clinical interview [15]. The 10/66 algorithm was previously
developed and successfully validated in 26 countries [16],
and its prospective validity has been confirmed [17]. Demen-
tia severity (no dementia; questionable dementia; mild,
moderate, and severe dementia) was determined by opera-
tionalizing theWashington University CDR criteria combin-
ing cognitive and functional information obtained from
informants and patients, as detailed by Morris and col-
leagues [18].2.4. Covariates
Age was established by consensus from the participant,
informant, and documentation. Education was subdivided
into five categories (no formal education, some formal edu-
cation but less than primary, primary education completed,
secondary education completed, and tertiary education com-
pleted). Socioeconomic status was measured by asking
about household living circumstances (marital status and
number of family members) and number of assets (motor ve-
hicle, television, refrigerator and/or freezer, water, electric-
ity, telephone, plumbed toilet/bathroom). Dietary habits
were evaluated by asking participants the following ques-
tions: “How often do you eat meat/fish?” (4-point scale;
never, some days, most days, or every day) and “How
many portions of fruit and vegetables have you eaten in
the last 3 days?” (number of portions reported). Self-
reported physical activity was coded as very physically ac-
tive, fairly physically active, not very physically active,
and not at all physically active. Smoking status was coded
as never, previous, or current. Hazardous drinking was de-
fined as .21 units per week for men and .14 for women.
Food insecurity (defined as any shortage of food that caused
persistent hunger) and self-reported medical diagnoses of se-
vere gastrointestinal disease, stroke, diabetes and ischemic
heart disease were enquired about. Resting blood pressure
was measured, and hypertension was defined as self-
reported treatment or resting average systolic blood pressure
140 mmHg and/or average diastolic blood pressure 95
mmHg. Waist and arm circumferences were measured to
the nearest centimeter (details have been previously re-
ported) [10].
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All analyses were performed on release 3.0 of the 10/66
data archive using Stata 11 (Stata Corp. College Station,
TX) for men and women and urban/rural sites combined, ad-
justing for gender after having confirmed that the interaction
terms of CDR with sex and urban/rural site on reported
weight loss were not significant (P 5 .61 and .09, respec-
tively). We combined the CDR “moderate” and “severe” de-
mentia groups because of the paucity of severe dementia
cases, and we used weight loss as a dichotomous dependent
variable. We entered CDR as a categorical variable in Pois-
son models accounting for household clustering, and we cal-
culated prevalence ratios (PRs) with robust 95% confidence
intervals (CI) by country. Models were adjusted in stages for
sociodemographic, lifestyle, and health characteristics, in-
cluding reported preexisting vascular disease and dietary
habits. In further adjusted models, we tested the robustness
of these associations, also accounting for waist and arm cir-
cumferences, and we performed Sobel-Goodman mediation
tests [7] to quantify the percentage of the total effect of de-
mentia severity that was mediated by these anthropometric
measures. We formally tested the existence of an incremen-
tal effect of dementia through stages of severity comparing
PRs by CDR category using Wald tests by country. We
measured between-country heterogeneity in the above asso-
ciations using the Q-test and Higgins I2 obtained from fixed-
effects meta-analytic models [19]. A fixed-effects model
was chosen to make inferences about the common effect
conditional on the 10/66 study centers. Random-effects
models were not used because we did not aim to generalize
to a hypothetical population of centers. We finally calculated
pooled meta-analytic estimates for CDR 0.5, 1, and 2/3 com-
pared with CDR 0 (i.e., no dementia), accounting for sample
sizes and variances in country-specific estimates.
Ethical approval for the study was obtained from the Re-
search Ethics Committee at King’s College London and by
local committees at each study site. Participants provided
written informed consent: witnessed oral consent in the
case of illiteracy or next-of-kin agreement in the case of in-
capacity or cognitive impairment.3. Results
Response rates in all countries were high (.80%). The
characteristics of participants (n 5 16,538) with complete
data are reported in Table 1. Weight loss prevalence ranged
from 2% in China to 26% in the Dominican Republic, and it
was lowest for participants with a CDR of 0 (i.e., no demen-
tia) and highest in those with a CDR of
2/3 in all countries (Table 2). In the latter CDR category,
the proportion (40.3%) of caregivers who reported weight
loss discrepantly from participants was significantly higher
(P 5 .002) compared with proportions in the less severe
dementia categories (31.5% and 30.9% for CDR 0.5 and
CDR 1, respectively).As previously reported [20], life circumstances and so-
ciodemographic, lifestyle, and health characteristics varied
by country, but relatively little of this variation was associ-
ated with weight loss status (Table 1). Those reporting
weight loss were older, more likely to be female (except
in Mexico), had a lower educational level (except in
China), had fewer household assets, were equally likely
to live alone or with their spouse only (except in China
and India), and were more or as likely to be smokers (ex-
cept in Cuba and China). They reported eating fewer por-
tions of meat, fish, and fruits or vegetables per week and
had higher food insecurity compared with those who did
not lose weight. Those who reported losing weight were
less physically active and were more likely to have three
or more physical impairments, including severe gastroin-
testinal disease and clinically diagnosed stroke, heart dis-
ease, and diabetes, and they had smaller arm and waist
circumferences compared with those who did not report
weight loss (Table 1). Correlations between reported
weight loss and arm (27.1%) and waist (24.7%) circum-
ferences were low.
In unadjusted and fully adjusted models, dementia sever-
ity was positively associated with reported weight loss in all
countries. Results were substantially unchanged after ad-
justments for waist and arm circumferences, although the
mediation effects of arm and waist circumference were sta-
tistically significant (Sobel P , .001) with 1.4% and 0.5%,
respectively, of the total effect (of CDR on reported weight
loss) being mediated. In model 1, reported weight loss was
incrementally associated with dementia severity such that
those with mild dementia (CDR 1) were from three- (in
Peru) to nearly eight-fold (in China) more likely to report
weight loss compared with participants without dementia
(Table 3). This incremental trend was significantly consis-
tent across countries (all Wald tests for trend P
values were,.001) (Table 3). Associations were only mod-
erately attenuated when we controlled for sociodemo-
graphic, lifestyle, and life circumstances (model 2), and
they were somewhat further attenuated when we add-
itionally controlled for health characteristics (model 3)
(Table 3). In fully adjusted models, the between-country het-
erogeneity was low or moderate (Table 3). The fixed-method
meta-analytic pooled estimates confirmed the incremental
trend in the association between dementia severity and re-
ported weight loss observed at a country level (P , .001)
(Fig. 1 and Figs. e-1–e-3).4. Discussion
Dementia severity was independently associated with
reported weight loss in .16,000 older adults (65) from
eight countries with low and middle incomes. The associa-
tion strengthened through stages of dementia severity, and
it was not explained by covariates including low arm/waist
circumferences and preexisting vascular disease. This asso-
ciation was highly consistent across countries, despite the
Table 1
Characteristics of 10/66 study participants by country and by reported weight loss
Weight
loss Cuba
Dominican
Republic Peru Venezuela Mexico China India Puerto Rico
Response rate, % 94 95 84 80 85 85 85 92
Missing values, n 42 75 68 210 39 6 34 19
Sample size, n (%) No 2669 (92) 1435 (74) 1499 (80) 1449 (83) 1723 (88) 2116 (98) 1679 (85) 1743 (88)
Yes 233 (8) 501 (26) 366 (20) 306 (17) 241 (12) 40 (2) 291 (15) 247 (12)
Age, mean (SD) No 74.9 (7) 74.8 (7.3) 74.6 (7.3) 72.0 (6.6) 74.2 (6.6) 73.2 (6.1) 71.7 (5.9) 76.0 (7.1)
Yes 77.1 (7.5) 76.3 (7.8) 75.0 (7.1) 74.1 (7.4) 74.9 (6.6) 74.7 (6.4) 73.0 (6.1) 78.7 (8.6)
Females, n (%) No 1717 (64) 931 (65) 912 (61) 896 (62) 1095 (64) 1188 (56) 945 (56) 1173 (67)
Yes 170 (73) 350 (70) 232 (63) 220 (72) 145 (60) 25 (63) 159 (55) 168 (68)
Less than primary education, n (%) No 637 (24) 992 (69) 276 (18) 430 (30) 1210 (70) 1054 (50) 1259 (75) 382 (22)
Yes 80 (34) 381 (76) 71 (19) 104 (34) 176 (73) 19 (48) 244 (84) 75 (30)
Less than three assets, n (%) No 67 (2.5) 197 (13.7) 69 (4.6) 21 (1.5) 369 (21.4) 112 (5.3) 831 (49.5) 3 (0.2)
Yes 9 (3.9) 97 (19.4) 24 (6.6) 13 (4.3) 54 (22.4) 1 (2.5) 206 (70.8) 1 (0.4)
Live alone or with spouse only, n (%) No 640 (24.0) 295 (20.6) 212 (14.1) 157 (10.8) 462 (26.8) 692 (32.7) 327 (19.5) 1016 (58.3)
Yes 50 (21.5) 82 (16.4) 54 (14.7) 23 (7.5) 54 (22.4) 17 (42.5) 77 (26.5) 116 (47.0)
Current smoker, n (%) No 523 (20) 173 (12) 52 (3) 166 (11) 155 (9) 490 (23) 544 (32) 85 (5)
Yes 36 (15) 67 (13) 14 (4) 34 (11) 22 (9) 7 (18) 122 (42) 16 (6)
Eat meat less than once a week, n (%) No 90 (3) 74 (5) 98 (7) 259 (18) 141 (8) 56 (3) 313 (19) 101 (6)
Yes 10 (4) 33 (7) 49 (13) 76 (25) 31 (13) 3 (8) 56 (19) 14 (6)
Eat fish less than once a week, n (%) No 246 (9) 473 (33) 124 (8) 57 (4) 488 (28) 60 (3) 346 (21) 401 (23)
Yes 38 (16) 178 (36) 27 (7) 19 (6) 65 (27) 5 (13) 67 (23) 72 (29)
Vegetables/fruits servings per week,
mean (SD)
No 4.8 (3.6) 3.2 (3.2) 4.2 (2.8) 4.6 (3.5) 4.4 (3.6) 11.3 (4.8) 4.4 (2.5) 3.9 (2.3)
Yes 4.5 (3.4) 2.6 (2.9) 4.5 (3.0) 4.4 (3.6) 4.4 (3.6) 10.3 (3.7) 6.5 (2.8) 3.3 (2.4)
Have any food insecurity, n (%) No 118 (4) 136 (9) 93 (6) 73 (5) 107 (6) 12 (1) 271 (16) 22 (1)
Yes 21 (9) 88 (18) 39 (11) 31 (10) 15 (6) 0 (0) 76 (26) 10 (4)
Not physically active, n (%) No 823 (31) 467 (33) 410 (27) 449 (31) 576 (33) 1063 (50) 222 (13) 583 (33)
Yes 119 (51) 245 (49) 154 (42) 156 (51) 115 (48) 31 (78) 82 (28) 136 (55)
Physical impairments (3), n (%) No 250 (9) 261 (18) 157 (10) 327 (23) 271 (16) 230 (11) 146 (9) 333 (19)
Yes 38 (16) 184 (37) 94 (26) 115 (38) 65 (27) 15 (38) 62 (21) 93 (38)
Have gastrointestinal problems, n (%) No 221 (8) 239 (17) 170 (11) 256 (18) 248 (14) 73 (3) 58 (3) 317 (18)
Yes 32 (14) 132 (26) 89 (24) 77 (25) 49 (20) 6 (15) 15 (5) 74 (30)
Reported clinical diagnosis of
stroke, n (%)
No 194 (7) 105 (7) 95 (6) 81 (6) 104 (6) 110 (5) 25 (1) 131 (8)
Yes 31 (13) 62 (12) 33 (9) 40 (13) 30 (12) 14 (35) 4 (1) 37 (15)
Reported clinical diagnosis of heart
problems, n (%)
No 217 (8) 56 (4) 44 (3) 123 (8) 55 (3) 350 (17) 20 (1) 73 (4)
Yes 20 (9) 35 (7) 23 (6) 43 (14) 7 (3) 10 (25) 3 (1) 23 (9)
Waist circumference, mean (SD) No 88.6 (13.2) 92.8 (12.8) 92.3 (9.6) 93.0 (11.5) 93.6 (10.7) 89.4 (11.3) 81.4 (10.6) 95.3 (13.3)
Yes 83.5 (12.5) 90.6 (12.9) 90.5 (10.3) 91.8 (12.2) 92.9 (12.4) 86.4 (9.5) 78.1 (11.3) 92.7 (14.4)
Arm circumference, mean (SD) No 27.6 (5.3) 31.1 (6.9) 28.2 (4.3) 28.8 (7.9) 25.9 (4.4) 33.7 (5.5) 23.9 (4.0) 29.9 (5.1)
Yes 25.8 (4.8) 30.5 (6.9) 27 (4.8) 27.9 (4.7) 25.7 (4.9) 32.5 (6.2) 22.9 (3.4) 28.7 (4.9)
Reported clinical diagnosis of
diabetes, n (%)
No 479 (18) 188 (13) 134 (9) 210 (14) 362 (21) 193 (9) 150 (9) 554 (32)
Yes 58 (25) 88 (18) 36 (10) 62 (20) 67 (28) 10 (25) 31 (11) 85 (34)
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economic differences in the sample characteristics that
would result in different confounding structures in each
study site.
There are limitations in our study. Weight loss was self-
reported; therefore, measurement error cannot be excluded
and might have diluted our findings. This was because
height and weight could not be feasibly measured in this
large population-based study, which was performed in
underresourced settings. The reliability of reported body
weight and height has been reported to decrease with age
[21]; however, cognitive status was unlikely to bias the in-
formation elicited in our study because this information
was confirmed by an informant in all dubious cases
(w30% of participants with some cognitive impairment
[CDR 0.5] who did not report weight loss). It is plausible
that self-report would become less reliable at worse demen-tia severity, but this would result in measurement error and
a bias toward the null. Our results confirmed this assump-
tion, because .40% of informants reported weight loss in
patients with more severe dementia (CDR 2/3) who did
not report weight loss themselves. It is important to bear
in mind that the catchment area sampling procedure cannot
be assumed to provide nationally representative samples,
and our findings should be generalized with caution. How-
ever, comparisons between country samples were appropri-
ate, and internal validity was preserved through the
standardized use of the 10/66 cross-culturally prevalidated
research protocols [11]. Moreover, although CDR accuracy
was probably lower than might be expected in clinical set-
tings, all interviewers underwent intensive standardized 1-
week training sessions and were closely supervised by local
geriatricians and neurologists [11]. The cross-sectional de-
sign is another limitation of our study. Weight loss may
Table 2
Numbers of participants by dementia severity in each country and number (%) of those who lost weight by country and dementia severity
Country
Dementia severity
CDR 0 CDR 0.5 CDR 1 CDR 2/3
Total* Lost weighty Total* Lost weighty Total* Lost weighty Total* Lost weighty
Cuba (n 5 2902) 1655 (57.0) 75 (4.5) 967 (33.3) 88 (9.1) 161 (5.6) 40 (24.8) 119 (4.1) 30 (25.2)
Dominican Republic (n 5 1936) 855 (44.2) 97 (11.4) 851 (44.0) 272 (32.0) 173 (8.9) 92 (53.2) 57 (2.9) 40 (70.2)
Peru (n 5 1865) 1192 (63.9) 157 (13.2) 522 (28.0) 136 (26.1) 105 (5.6) 44 (41.9) 46 (2.5) 29 (63.0)
Venezuela (n 5 1755) 923 (52.6) 93 (10.1) 734 (41.8) 166 (22.6) 76 (4.3) 32 (42.1) 22 (1.3) 15 (68.2)
Mexico (n 5 1964) 918 (46.7) 52 (5.7) 913 (46.5) 142 (15.6) 113 (5.8) 38 (33.6) 20 (1.0) 9 (45.0)
China (n 5 2156) 1380 (64.0) 9 (0.7) 659 (30.6) 16 (2.4) 77 (3.6) 4 (5.2) 40 (1.9) 11 (27.5)
India (n 5 1970) 1076 (54.6) 62 (5.8) 785 (39.9) 187 (23.8) 93 (4.7) 34 (36.6) 16 (0.8) 8 (50.0)
Puerto Rico (n 5 1990) 1104 (55.5) 64 (5.8) 695 (34.9) 103 (14.8) 131 (6.6) 49 (37.4) 60 (3.0) 31 (51.7)
All sample (n 5 16,538) 9103 (55.0) 609 (6.7) 6126 (37.0) 1110 (18.1) 929 (5.6) 333 (35.8) 380 (2.3) 173 (4.5)
NOTE. Data are numbers (%).
*Denominators are total participants in each country.
yDenominators are participants in each dementia severity group by country.
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directionality in the observed association cannot be disen-
tangled and reverse causality (i.e., weight loss causing
more severe dementia) cannot be excluded. In fact, because
impairment in activities of daily living (ADL) is part of the
CDR construct, those with dementia who have another co-
morbid condition that may cause weight loss and impair-
ment in ADL might be ranked with a more advanced
CDR. Dementia and weight loss are recognized to increase
mortality risk [22,23]; therefore, survival bias might have
occurred, although it most likely diluted rather than
exaggerated true associations.
The geographic and cultural diversity of our sample is
a major strength of our study, along with the very large sam-
ple size and the dementia algorithm, on the basis of measure-
ments previously validated in over 20 countries [16].
However, given the size of the sample and settings, it was
not possible to screen for nutritional deficiencies or deter-
mine APOE polymorphisms that might have confounded
or modified the association between dementia severity and
weight loss [24], and dementia subtypes were not considered
in the present study. The magnitude of the associations re-
mained marked in all countries, and it was largely unaffected
after adjustment for a range of potential confounders, includ-
ing life circumstances, dietary habits, and sociodemographic
and health characteristics. Residual confounding cannot be
excluded; however, the high homogeneity of our results
across widely differing countries renders this less likely,
which is additionally supported by the well-established evi-
dence for an association between dementia and weight loss
in Western settings.
Frail elders have poorer health and an increased mortal-
ity risk [25], and the association between dementia and
weight loss has been consistently reported in clinical set-
tings [26]. In prospective population-based studies, weight
loss has been found to be associated with dementia even at
mild severity, increasing with advancing disease severity
and duration [27]. Our results are consistent with previousstudies. Weight loss accelerated after, but also preceded,
the symptomatic onset of dementia in samples of Japanese
Americans [5], in Americans of Caucasian background [6],
in Europeans [28], and in Americans of African origin [29]
and Nigerians [30]. Similar findings have been reported in
a prospective study of Australian men [31] and in a case-
control study from Hong-Kong [32]. The homogeneity of
our findings across world regions has not been previously
reported. The present analysis extends previous findings
in these samples of relatively consistent cross-sectional
associations for dementia with smaller arm and waist cir-
cumference [10]; however, low arm and waist circumfer-
ence only very marginally mediated the associations
between reported weight loss and dementia severity. The
novel homogeneity of our findings across very diverse set-
tings, obtained using highly standardized methods, sug-
gests that the association between dementia and weight
loss may be relatively unaffected by ethnicity or geograph-
ical region.
Although this study did not seek to identify potential un-
derlying mechanisms linking dementia with weight loss, its
finding of relative homogeneity for this association in di-
verse populations should be taken into account when such
mechanisms are being considered. Causal pathways may
well vary during the disease course such that relative weight
loss before the clinical onset of dementia and occurring af-
terward may have different underlying mechanisms [2].
For example, severity of dementia is accompanied by pro-
gressive functional impairment and worsening of behavioral
and psychological symptoms as well as comorbid conditions
that may result in reduced food intake, although these less
obviously account for the weight loss that precedes the
clinical onset. In Alzheimer’s disease (which plausibly ac-
counted for most dementia cases in our study), atrophy of
the medial temporal lobe (a proxy for limbic system damage
implicated in appetite control) and the hippocampal forma-
tion are early neuropathological features that might be impli-
cated early on [33,34]. Low BMI has also been found to be
Table 3
PR* and 95% CI for the association between dementia severity and weight loss compared with no dementia
Country
Dementia severity
CDR 0.5 CDR 1 CDR 2/3 P valuey
Model 1
Cuba 2.01 (1.50–2.70) 5.45 (3.83–7.74) 5.33 (3.63–7.85) ,.001
Dominican Republic 2.79 (2.26–3.46) 4.67 (3.69–5.92) 6.14 (4.76–7.93) ,.001
Peru 1.97 (1.60–2.44) 3.18 (2.40–4.21) 4.77 (3.65–6.23) ,.001
Venezuela 2.18 (1.73–2.76) 4.06 (2.93–5.63) 6.45 (4.56–9.12) ,.001
Mexico 2.77 (2.04–3.75) 5.90 (4.07–8.55) 8.12 (4.69–14.06) ,.001
China 3.68 (1.63–8.32) 7.94 (2.49–25.38) Not calculable ,.001
India 4.15 (3.16–5.46) 6.36 (4.44–9.10) 8.76 (5.10–15.05) ,.001
Puerto Rico 2.57 (1.91–3.45) 6.50 (4.70–8.98) 8.88 (6.26–12.58) ,.001
Model 2
Cuba 1.89 (1.40–2.55) 4.30 (2.94–6.30) 3.53 (2.20–5.67) ,.001
Dominican Republic 2.57 (2.08–3.19) 4.19 (3.27–5.35) 5.81 (4.36–7.76) ,.001
Peru 1.88 (1.50–2.34) 3.11 (2.32–4.18) 4.67 (3.22–6.77) ,.001
Venezuela 2.05 (1.61–2.61) 3.27 (2.28–4.70) 4.12 (2.61–6.51) ,.001
Mexico 2.79 (2.05–3.80) 5.72 (3.83–8.56) 7.11 (3.67–13.75) ,.001
China 2.69 (1.16–6.24) 2.67 (0.79–8.98) 15.36 (5.96–39.57) ,.001
India 3.23 (2.43–4.31) 4.19 (2.85–6.14) 5.86 (2.90–11.87) ,.001
Puerto Rico 2.52 (1.86–3.40) 4.98 (3.43–7.24) 6.86 (4.57–10.31) ,.001
Model 3
Cuba 1.87 (1.39–2.52) 4.29 (2.92–6.31) 3.45 (2.15–5.20) ,.001
Dominican Republic 2.41 (1.94–2.99) 4.01 (3.13–5.12) 5.46 (4.01–7.34) ,.001
Peru 1.64 (1.32–2.06) 2.92 (2.15–3.96) 4.66 (3.14–6.93) ,.001
Venezuela 1.96 (1.53–2.50) 2.86 (1.95–4.20) 4.05 (2.58–6.37) ,.001
Mexico 2.58 (1.89–3.52) 5.03 (3.31–7.65) 7.08 (3.56–14.09) ,.001
China 2.89 (1.18–7.07) 1.86 (0.40–8.78) 16.44 (5.62–48.06) ,.001
India 3.08 (2.31–4.11) 4.03 (2.73–5.95) 5.43 (2.57–11.46) ,.001
Puerto Rico 2.43 (1.80–3.27) 4.69 (3.21–6.84) 6.94 (4.57–10.53) ,.001
Meta-analysisz
Pooled estimate (95% CI) 2.19 (1.98–2.41) 3.81 (3.35–4.33) 5.18 (4.41–6.10) ,.001
Cochrane Q (P value) Q 5 16.393 Q 5 9.350 Q 5 11.929
(7 degrees of freedom) P 5 .022 P 5 .229 P 5 .103
Higgins I2, % (95% CI) 57 (6–81) 25 (0–66) 41 (0–74)
NOTE. Model 1 was adjusted for gender. Model 2 was adjusted for gender, age, education, number of assets, food insecurity (week frequency of hunger
through shortage of food), living circumstances (live alone or with spouse only vs larger families arrangements), physical activity level (inactive, mild, mod-
erate, high level), smoke status (never, ex-, current smoker), week meat and fish (none, some, or most days), and week portions of fruits and vegetables. Model 3
was additionally adjusted for number of physical impairments (3) and reported clinical diagnosis of stroke, diabetes, and gastrointestinal and heart disease.
*PRs are from Poisson models with robust 95% CI adjusted for household clustering.
yWald test postestimations for linear hypothesis.
zMeta-analysis of country estimates from model 3.
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adults followed to postmortem [3]. Moreover, structural
changes due to dementia may lead to hypothalamic dysfunc-
tion [35] and hypometabolism of the cingulate or hypothal-
amus [36], both of which may alter appetite control and
energy metabolism [37]. Vascular pathways might also be
implicated in any of these processes. In our study, adjust-
ment for vascular disease and vascular risk factors had little
effect on the association between dementia and weight loss
in our analyses.
The sequelae of weight loss encompass increased mortal-
ity [23], morbidity, and worse prognosis in people with de-
mentia [27]. Prevention and treatment of weight loss in
dementia patients may improve the health status of the pa-
tients [2]. However, the effectiveness of nutritional interven-
tions remains to be verified. Some interventions might be
efficacious in dementia prevention [38], and treatment ofweight loss is deemed critical in clinical settings and is
highly recommended, particularly for institutionalized de-
mentia patients [2]. The public health implications of weight
loss prevention and treatment in dementia may be of partic-
ular relevance in LAMICs, where most of all dementia cases
currently reside and where the steepest increases in numbers
are also predicted [7]. Risk of malnutrition may be high, fi-
nancial resources are scarce, and health systems are not de-
signed for chronic diseases in these settings [39]. Evidence
from further prospective observational and experimental
studies would be helpful, and specific interventions should
be designed and tailored to the significant cultural and re-
source diversities among non-Western countries. It is con-
ceivable that simple and cost-effective recommendations
to maintain or increase caloric intake of dementia patients
may be predicted on precautionary principles of good clini-
cal practice.
Fig. 1. Increase in weight loss risk by dementia severity. Pooled estimates
are from country-specific, fully adjusted Poisson models using fixed-effects
method meta-analysis as for model 3 in Table 3 (i.e., adjusted for gender;
age; education; number of assets; food insecurity [week frequency of hunger
through shortage of food]; living circumstances [live alone or with spouse
only vs larger families arrangements]; physical activity level [inactive,
mild, moderate, high level]; smoking status [never, ex-, current smoker];
week meat and fish [none, some, or most days]; week portions of fruits
and vegetables; number of physical impairments [3]; and reported clinical
diagnosis of stroke, diabetes, and gastrointestinal and heart disease.
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study.RESEARCH IN CONTEXT
1. Systematic review: We searched Ovid and Medline
databases for studies on weight loss and dementia
since 1980. We combined free text and MeSH terms,
including “Dementia,” “Cognitive Impairment,”
(AND) “Weight loss” (OR) “epidemiology.” Rele-
vant studies’ quality was critically appraised consid-
ering study design and quality of reporting (on the
basis of PRISMA recommendations).
2. Interpretation: In .17,000 older adults across di-
verse LAMICs, there was a strong gradient effect
in the direct association between dementia severity
and reported weight loss. In view of the effect of
weight loss on morbidity and mortality, our results
may have relevant public health implications.
3. Future directions: The association between dementia
and weight loss should be studied prospectively, and
body composition changes (i.e., in fat and lean mass)
should be further investigated. The efficacy and ef-
fectiveness of nutritional interventions designed to
ameliorate weight loss in dementia patients should
be investigated, particularly in less resourced set-
tings.
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